PM Boris Johnson Meets Bill Gates to Discuss Implementing ‘Global’ Vaccine Program. Gates and Big Pharma call the Shots

Boris Johnson intends to use Britain’s presidency of G7 in 2021 to implement Gates Foundation’s “global approach” to “health security”

The British Prime Minister Boris Johnson, currently being criticised for imposing another lockdown based on questionable data, has met with Bill Gates to discuss implementing a global “health security” program using Britain’s G7 presidency to speed up the process.

Johnson met with Gates along with the CEOs of ten of the world’s biggest pharmaceutical companies to foment plans to roll out the vaccine for coronavirus.

Every CEO agreed to commit to providing “fair” access across the globe to the vaccine when it is ready.

Johnson said that the opportunity the G7 presidency in 2021 affords Britain will allow the nation to spearhead a global health plan developed by the Bill and Melinda Gates Foundation in partnership with the Wellcome Trust.

The plan was unveiled by Gates at the UN in September, where he called for  overhauling big pharma’s capacity to manufacture “vaccines and treatments.”

Johnson hailed the effort as a “new era of collaboration for problem solving,” and “pandemic preparedness,” adding that it will be a “truly global endeavor”.

The Prime Minister said that world leaders should have heeded Gates’ warnings years ago, and must now work with his Foundation to prevent “something like [Covid-19] ever happening again.”

Gates noted that “the world needs a comprehensive strategy; a coherent approach to financing and manufacturing billions of doses of vaccines, tests and drugs; and a network to monitor for new threats.”

“We’re fortunate that Prime Minister Johnson has come up with a smart plan to do just that in the UK, and our foundation will continue to work with his government and others to make it a reality,” Gates added.

The British government is preparing to roll out the coronavirus vaccine on a level never before seen, drafting in the army to man vaccination centres at arenas, sports halls, and shopping malls.

It has been described as “the biggest logistical effort since the Second World War.”

Gates has previously declared that the world won’t return to normal until “a lot of people” take a second “super-effective” coronavirus vaccine that could be years away.

Last week, we Gates has forcast that a “best case scenario” for a return to normal would be the end of 2021, a date that was qualified with the proviso, “We still don’t know whether these vaccines will succeed.”

The billionaire has also suggested that governments need to ‘brainstorm’ ways of “reducing vaccine hesitancy,” in the face of anti-vaccine “conspiracy theories”.

*

Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.


Articles by: Steve Watson

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]